Risk Factors for Community-Onset Pneumonia Caused by Levofloxacin-Nonsusceptible Streptococcus pneumoniae

被引:8
作者
Seok, Hyeri [1 ]
Kang, Cheol-In [1 ]
Huh, Kyungmin [1 ]
Cho, Sun Young [1 ]
Ha, Young Eun [1 ]
Chung, Doo Ryeon [1 ]
Peck, Kyong Ran [1 ]
机构
[1] Sungkyunkwan Univ, Div Infect Dis, Dept Med, Samsung Med Ctr,Sch Med, 81 Irwon Ro, Seoul 06531, South Korea
关键词
S; pneumoniae; levofloxacin-nonsusceptible; community-onset pneumonia; risk factor; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; INFECTION; SUSCEPTIBILITIES; PREVALENCE; PATHOGENS; CHILDREN;
D O I
10.1089/mdr.2017.0416
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Fluoroquinolones are antibiotics commonly used in the treatment of infections caused by Streptococcus pneumoniae. However, rates of fluoroquinolone resistance are increasing with their frequent use. We designed this study to verify current fluoroquinolone resistance rates and risk factors for community-onset pneumococcal pneumonia. Methods: A retrospective case-control study was conducted in a tertiary referral hospital. The study population comprised patients admitted for pneumococcal pneumonia between January 2011 and May 2017. The case group included community-onset pneumonia caused by levofloxacin-nonsusceptible S. pneumoniae. The control group consisted of two patients with levofloxacin-susceptible S. pneumoniae who were admitted around the same time as each case. Results: A total of 198 pneumococcal pneumonia cases were identified during the study period. Twenty-five levofloxacin-resistant S. pneumoniae cases and 3 levofloxacin-intermediate S. pneumoniae cases were included in the case group (nonsusceptibility rate=14.1%). Multivariate analysis showed that healthcare-associated factors (odds ratio [OR] 4.78, 95% confidence interval [CI] 1.39-16.43, p=0.013), bronchopulmonary disease (OR 3.79, 95% CI 1.07-13.40, p=0.039), cerebrovascular disease (OR 6.08, 95% CI 1.24-29.75, p=0.026), and exposure to fluoroquinolones within the previous 3 months (OR 5.89, 95% CI 1.21-28.68, p=0.028) were associated with nonsusceptibility to levofloxacin. Conclusion: Independent risk factors for levofloxacin-nonsusceptible pneumococcal pneumonia were recent hospitalization, bronchopulmonary disease, cerebrovascular disease, and prior antibiotic use within 3 months. Careful selection of empirical antibiotics is thus needed in at-risk patients. Similarly, efforts to prevent the interpersonal spread of drug-resistant pathogens in long-term care facilities and to restrict unnecessary fluoroquinolone prescriptions are important.
引用
收藏
页码:1412 / 1416
页数:5
相关论文
共 50 条
  • [31] Clinical factors influencing the performance of bacterial multiplex polymerase chain reaction in patients with community-onset pneumonia
    Ga Eun Park
    Kyong Ran Peck
    Jae-Hoon Ko
    Cheol-In Kang
    Sun Young Cho
    Doo Ryeon Chung
    Nam Yong Lee
    European Journal of Clinical Microbiology & Infectious Diseases, 2020, 39 : 1193 - 1199
  • [32] Emergence of Community-Acquired Adenovirus Type 55 as a Cause of Community-Onset Pneumonia
    Cao, Bin
    Huang, Guo-Hong
    Pu, Zeng-Hui
    Qu, Jiu-Xin
    Yu, Xiao-Min
    Zhu, Zhen
    Dong, Jian-Ping
    Gao, Yan
    Zhang, Yong-Xiang
    Li, Xiao-Hui
    Liu, Jian-Hua
    Wang, Hong
    Xu, Qian
    Li, Hui
    Xu, Wenbo
    Wang, Chen
    CHEST, 2014, 145 (01) : 79 - +
  • [33] Comparison of Clinical Prediction Models for Resistant Bacteria in Community-onset Pneumonia
    Self, Wesley H.
    Wunderink, Richard G.
    Williams, Derek J.
    Barrett, Tyler W.
    Baughman, Adrienne H.
    Grijalva, Carlos G.
    ACADEMIC EMERGENCY MEDICINE, 2015, 22 (06) : 730 - 740
  • [34] Risk factors of community-onset extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteraemia in South Korea using national health insurance claims data
    Lee, Yongseop
    Kim, Young Ah
    Kim, Dokyun
    Shin, Jong Hee
    Uh, Young
    Shin, Kyeong Seob
    Shin, Jeong Hwan
    Jeong, Seok Hoon
    Park, Yoon Soo
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (06) : 723 - 727
  • [35] Characteristics of community-onset NDM-1-producing Klebsiella pneumoniae isolates
    Kim, So Yeon
    Rhee, Ji-Young
    Shin, Sang Yop
    Ko, Kwan Soo
    JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 63 : 86 - 89
  • [36] Bacteremic Streptococcus pneumoniae in Community-Acquired Pneumonia: An Update
    Sanz Herrero, Francisco
    Lloret Perez, Tomas
    Blanquer Olivas, Jose
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2010, 6 (03) : 188 - 193
  • [37] A case of necrotic pneumonia caused by Streptococcus pneumoniae was diagnosed using a pneumonia antigen test in BALF: A case report
    Huang, Yanjing
    Guo, Hongkun
    Li, Yiming
    MEDICINE, 2024, 103 (36) : e39571
  • [38] Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis
    Rodriguez-Bano, Jesus
    Picon, Encarnacion
    Gijon, Paloma
    Ramon Hernandez, Jose
    Ruiz, Maite
    Pena, Carmen
    Almela, Manuel
    Almirante, Benito
    Grill, Fabio
    Colomina, Javier
    Gimenez, Monserrat
    Oliver, Antonio
    Pablo Horcajada, Juan
    Navarro, Gemma
    Coloma, Ana
    Pascual, Alvaro
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (01) : 40 - 48
  • [39] Clinical features and risk factors of plastic bronchitis caused by Mycoplasma pneumoniae pneumonia in children
    Lei Yang
    Yuyan Zhang
    Changqing Shen
    Zhouhua Lu
    Tongshu Hou
    Fenghai Niu
    Yuzhong Wang
    Jun Ning
    Ruihan Liu
    BMC Pulmonary Medicine, 23
  • [40] Lower Mortality Rate in Elderly Patients With Community-Onset Pneumonia on Treatment With Aspirin
    Falcone, Marco
    Russo, Alessandro
    Cangemi, Roberto
    Farcomeni, Alessio
    Calvieri, Camilla
    Barilla, Francesco
    Scarpellini, Maria Gabriella
    Bertazzoni, Giuliano
    Palange, Paolo
    Taliani, Gloria
    Venditti, Mario
    Violi, Francesco
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (01):